Chronic inflammatory bowel diseases (IBD) are on the rise worldwide. About 20% of cases are diagnosed in the first two decades of life. For children and adolescents, IBD is a threat to their physical, psychosocial and professional development. Previous studies showed that delivery of care is not optimal in international studies, further increasing the risk of long term complications and impairment.
Statement of the GPGE working groups CEDATA and Nutrition/Nutrition Medicine AbstactEpidemiologische und klinische Beobachtungen sowie Tiermodelle weisen auf die Ernährung als Risikofaktor für die Entwicklung einer chronisch entzündlichen Darmerkrankung (CED) hin. Die exklusive enterale Ernährungstherapie Weiterlesen
ABSTRACT – Background and Aims: Intensifying therapy for Paediatric Crohn’s Disease (CD) by early use of immunomodulators and biologics has been proposed for cases in which predictors of poor outcome (POPO) were present. We investigated therapy Weiterlesen
DATA FROM THE CEDATA GPGE REGISTRY To date, failure of the first-line medical management of Crohn’s disease (CD) in children and adolescents has been followed by escalation treatment, with administration of immunomodulators, e.g., azathioprine, or Weiterlesen
0 Kommentare